Evidence map›Paper›PMID 37840694›Full record

ArticleMediators of inflammation2023

Dimethyl Fumarate Protects against Lipopolysaccharide- (LPS-) Induced Sepsis through Inhibition of NF-

He Fang, Xingtong Wang, Mahendra Damarla, Rongju Sun, Qingli He, Ruojing Li, Pengfei Luo, Jun O Liu, Zhaofan Xia

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Molecular medicine reports · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

He Fang *Department of Burn Surgery, The First Affiliated Hospital of Naval Medical University, 168 ChangHai Road, Yangpu District, Shanghai 200433, China.
Xingtong Wang *Department of Burn Surgery, The First Affiliated Hospital of Naval Medical University, 168 ChangHai Road, Yangpu District, Shanghai 200433, China.
Mahendra Damarla *Department of Pulmonary and Critical Care Medicine, The Johns Hopkins Hospital, 1830 E. Monument Street, Baltimore, MD 21287, USA.
Rongju SunDepartment of Burn Surgery, The First Affiliated Hospital of Naval Medical University, 168 ChangHai Road, Yangpu District, Shanghai 200433, China.
Qingli HeDepartment of Pharmacology and Molecular Sciences, School of Medicine, Johns Hopkins University, 725 North Wolfe Street, Baltimore, MD 21205, USA.
Ruojing LiDepartment of Pharmacology and Molecular Sciences, School of Medicine, Johns Hopkins University, 725 North Wolfe Street, Baltimore, MD 21205, USA.
Pengfei LuoDepartment of Burn Surgery, The First Affiliated Hospital of Naval Medical University, 168 ChangHai Road, Yangpu District, Shanghai 200433, China.
Jun O LiuDepartment of Pharmacology and Molecular Sciences, School of Medicine, Johns Hopkins University, 725 North Wolfe Street, Baltimore, MD 21205, USA.ORCID https://orcid.org/0000-0003-3842-9841
Zhaofan XiaDepartment of Burn Surgery, The First Affiliated Hospital of Naval Medical University, 168 ChangHai Road, Yangpu District, Shanghai 200433, China.ORCID https://orcid.org/0000-0001-8092-0699
Johns Hopkins University · USChinese Academy of Medical Sciences & Peking Union Medical College · CNJohns Hopkins Hospital · US

Funding

Targeting Divergent Roles of Caspase 3 to Promote Endothelial Barrier IntegrityR01HL133413 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI DAMARLA, MAHENDRA · 2016 to 2020
$2.0M
MAP Kinase Signaling in Apoptosis-Induced Ventilator-Associated Lung InjuryK08HL097024 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI DAMARLA, MAHENDRA · 2009 to 2013
$805k
NHLBI NIH HHS K08 HL097024NHLBI NIH HHS R01 HL133413
6 · The paper itself

Abstract

Sepsis is one of the most severe complications and causes of mortality in the clinic. It remains a great challenge with no effective treatment for clinicians worldwide. Inhibiting the release of proinflammatory cytokines during sepsis is considered as an important strategy for treating sepsis and improving survival. In the present study, we have observed the effect of dimethyl fumarate (DMF) on lipopolysaccharide- (LPS-) induced sepsis and investigated the possible mechanism. By screening a subset of the Johns Hopkins Drug Library, we identified DMF as a novel inhibitor of nitric oxide synthesis in LPS-stimulated RAW264.7 cells, suggesting that DMF could be a potential drug to treat sepsis. To further characterize the effect of DMF on LPS signaling, TNF-

Indexed as

NF-kappa BSepsisAnimalsCytokinesDimethyl FumarateInterleukin-6LipopolysaccharidesMiceMice, Inbred C57BLTumor Necrosis Factor-alphaCytokinesDimethyl FumarateInterleukin-6LipopolysaccharidesNF-kappa BTumor Necrosis Factor-alpha

Identifiers

PMID37840694
PMCPMC10569893
OpenAlexW4387362127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.